Abstract: The present invention relates to a method for quantification of target materials using a glucose meter and cell-free protein reaction in combination. Accordingly, the method for quantification of target materials according to the present invention can quantify target materials with high efficiency in a short time at a low cost, and thus can be useful in various industries.

Abstract: A cylindrical secondary battery includes an electrode assembly having a positive electrode/separator/negative electrode structure positioned in a cylindrical battery can. The cylindrical secondary battery comprises: a first insulating layer mounted at the upper end of the electrode assembly and having a first through hole through which the electrode tab penetrates, and a second insulating layer mounted at the upper end of the first insulating layer and having a second through hole formed to align with a central axis of the electrode assembly. A method of manufacturing the cylindrical secondary battery is also provided.

Abstract: A user terminal apparatus is provided. The user terminal device includes a display having a main display area disposed on a front side of the user terminal apparatus and a sub display area extended from one side of the main display area to be disposed on at least one area of a rear side of the user terminal apparatus and a processor configured to, in response to a predetermined touch input being input on the sub display area, control the display to display a UI displayed on the sub display area on the main display area.

Abstract: The present disclosure relates to a user recognition method and a user recognition apparatus using a two-dimensional (2D) electromyogram (EMG) spectrogram image. The user recognition method using a 2D EMG spectrogram image may include (a) acquiring a one-dimensional EMG signal for a user, (b) converting the acquired one-dimensional EMG signal to a 2D EMG spectrogram image including a temporal feature and a frequency feature, and (c) recognizing the user based on the 2D EMG spectrogram image.

Abstract: A foldable device includes: a flexible display including: a first part; a second part; and a third part provided between the first and second parts; a first body supporting the first part; and a second body supporting the second part, each of the first and second body are configured to move between a first and a second position, in response to each of the first and second bodies being provided in the first position, the first body and the second body form a receiving space, the third part forms a curved portion of the flexible display and the curved portion is provided within the receiving space, and wherein the first part is configured to move in a longitudinal direction of the flexible display with respect to the first body in response to the first and second bodies moving between the first and second positions.

Abstract: A semiconductor device having a super junction and a method of manufacturing the semiconductor device capable of obtaining a high breakdown voltage are provided, whereby charge balance of the super junction is further accurately controlled in the semiconductor device that is implemented by an N-type pillar and a P-type pillar. The semiconductor device includes a semiconductor substrate; and a blocking layer including a first conductive type pillar and a second conductive type pillar that extend in a vertical direction on the semiconductor substrate and that are alternately arrayed in a horizontal direction, wherein, in the blocking layer, a density profile of a first conductive type dopant may be uniform in the horizontal direction, and the density profile of the first conductive type dopant may vary in the vertical direction.

Abstract: Disclosed is a pharmaceutical composition for preventing or treating severe acute respiratory syndrome coronavirus 2 infection disease, the composition comprising a compound represented by a Chemical Formula 1, or a pharmaceutically acceptable salt thereof, as an active ingredient.

Abstract: Disclosed is a pharmaceutical composition for preventing or treating severe acute respiratory syndrome coronavirus 2 infection disease, the composition comprising a compound represented by a Chemical Formula 1, or a pharmaceutically acceptable salt thereof, as an active ingredient.

Abstract: Disclosed herein is an electrode assembly configured to have a structure in which a bi-cell and two or more monocells are folded in a state in which the bi-cell and the two or more monocells are arranged on a continuous separation film. The bi-cell includes electrodes in the form of at least one cathode and at least one anode stacked so that a separator is disposed between the cathode and the anode, the bi-cell having a first dimension in a first direction substantially equal to w. The two or more monocells each include electrodes in the form of at least one cathode and at least one anode stacked so that a separator is disposed between the cathode and the anode, each cathode and each anode of each monocell having a first dimension in the first direction substantially equal to 2 times the first dimension w of the bi-cell.

Abstract: A flexible electrode includes: a current collector; an electrode layer positioned at a top of the current collector; a first support layer positioned at a top of the electrode layer; and a second support layer positioned at a bottom of the current collector, wherein each of the first support layer and the second support layer is a conductive coating layer-containing porous polymer substrate including a porous polymer substrate, and a conductive coating layer positioned on a surface of the porous polymer substrate and including a conductive material and a dispersing agent, and the porous polymer substrate is a non-woven web provided with a plurality of polymer fibers and a pore structure interconnected by the plurality of polymer fibers.

Abstract: A foldable device includes: a flexible display including: a first part; a second part; and a third part provided between the first and second parts; a first body supporting the first part; and a second body supporting the second part, each of the first and second body are configured to move between a first and a second position, in response to each of the first and second bodies being provided in the first position, the first body and the second body form a receiving space, the third part forms a curved portion of the flexible display and the curved portion is provided within the receiving space, and wherein the first part is configured to move in a longitudinal direction of the flexible display with respect to the first body in response to the first and second bodies moving between the first and second positions.

Abstract: A semiconductor device having a super junction and a method of manufacturing the semiconductor device capable of obtaining a high breakdown voltage are provided, whereby charge balance of the super junction is further accurately controlled in the semiconductor device that is implemented by an N-type pillar and a P-type pillar. The semiconductor device includes a semiconductor substrate; and a blocking layer including a first conductive type pillar and a second conductive type pillar that extend in a vertical direction on the semiconductor substrate and that are alternately arrayed in a horizontal direction, wherein, in the blocking layer, a density profile of a first conductive type dopant may be uniform in the horizontal direction, and the density profile of the first conductive type dopant may vary in the vertical direction.

Abstract: Disclosed herein is a battery cell having an electrode assembly mounted in a battery case, the battery cell including an electrode assembly configured to have a stepped structure in which two or more electrodes or unit cells have different planar sizes and a battery case, wherein a receiving part of the battery case is provided on the inner surface thereof with at least one protrusion protruding toward the electrode assembly.

Abstract: The present invention relates to a novel exenatide analogue, which is an exenatide analogue in which the first to fifteenth amino acids from the C-terminal of the amino acid sequence of exenatide are deleted and a fatty acid is conjugated. The present invention provides a short length exenatide exhibiting almost the same level of anti-diabetic effects compared with that of conventional exenatide and liraglutide, which is an anti-diabetic drug, and capable of reducing the preparation cost of exenatide.

Abstract: A controller is provided to include a processor reading data from a memory device, and a decoder receiving the data and decoding the data, the data being represented with check nodes and variable nodes. The decoder includes a check unit calculating syndrome values, a calculation unit receiving the decision values of the variable nodes and calculating flipping function values, a setting unit receiving the flipping function values and generating a candidate vector by dividing the flipping function values into groups and selecting at least some maximum values from the groups, the setting unit setting a flipping function threshold value, and a flipping unit receiving the flipping function threshold value, comparing the flipping function values of the variable nodes with the flipping function threshold value, and flipping a decision value of a target variable node having a greater flipping function value than the flipping function threshold value.

Abstract: A flexible device includes: a display that may be bent by an external force; a sensor configured to sense at least one motion from the group consisting of a bending motion and a folding motion of the flexible device; and a controller configured to determine outer form information about the flexible device, which is obtained when the flexible device is deformed by the at least one motion, and control an object in a screen, displayed on the display, to be moved based on the outer form information.

Abstract: A method for operating a Low Density Parity Check (LDPC) decoder includes assigning each symbol of a codeword as a variable node value for each of a plurality of variable nodes, performing syndrome checking on each check node based on a parity check matrix, calculating flipping function values of the variable nodes based on syndrome values of check nodes and a flipping function, dividing the flipping function values into a plurality of groups, determining a flipping function threshold value based on a group maximum value of a group among the groups, and selectively flipping a variable node value based on a comparison result of a flipping function value of corresponding variable node and the determined flipping function threshold value.

Abstract: A foldable device includes a sensor configured to sense an unfolding motion of the foldable device, a display configured to display a layout in which a representation of at least one object varies according to the sensed unfolding motion, and a controller configured to control the display of the layout so that the representation of the at least one object corresponds to the sensed unfolding motion.

Abstract: An electronic device including a flexible display and a method thereof are disclosed herein. The electronic device may include the flexible display and a processor. The processor implements the method, including controlling the flexible display to divide a display area into a first area and a second area, controlling the flexible display to display a first graphic element related to a first application in the first area, and a second graphic element related to controlling the first application in the second area, and controlling the first application responsive to detecting an input to the second graphic element.

Abstract: The present invention relates to a nanocomposite for detecting hydrogen sulfide; a method for preparing the same; a novel reactive fluorogenic compound to be used in the method; a kit for detecting hydrogen sulfide comprising the nanocomposite; and a method for providing information for the diagnosis of a disease, which causes abnormal secretion of hydrogen sulfide, by using the nanocomposite.